The possibilities of studying the function of neurotransmitter systems in the human brain are limited and our knowledge is to a great extent based on analogies from animal experiments. In the last years, however, biochemical analyses of the monoamine transmitters noradrenaline, dopamine, and 5-hydroxytryptamine in brain material obtained at necropsy (Ehringer and Hornykiewicz, 1960) and of their metabolites in the cerebrospinal fluid (CSF) (Guldberg, Turner, Hanieh, Ashcroft, Crawford, Perry, and Gillingham, 1967; Johansson and Roos 1967) have given new approaches to the study of these transmitters in man.
The cholinergic transmitter acetylcholine (ACh), however, cannot be investigated in brain material from necropsy due to a rapid postmortem change of the ACh concentration. Further, investigations on ACh in the CSF have so far been rather inconclusive and its occurrence as a normal constituent of CSF has been a matter of controversy (Schain, 1960; Duvoisin and Dettbarn, 1967) . The cholinergic precursor and end-product choline (Ch) is, on the other hand, detectable in the CSF in a fairly low con-1 A preliminary report of this work was presented at the XXVth Scandinavian Pharmacological Meeting, Copenhagen 1971. 2 Present address: Department of Neurology, University of Uppsala, Sweden. 720 centration. We thus raised the question whether a change in the concentration of Ch in human CSF could reflect an altered cholinergic activity in the central nervous system. In Parkinson's disease, evidence points to a cholinergic dominance in the striatum due to a decreased dopaminergic inhibition on cholinergic neurones in this region (Calne, 1970) . In Huntington's chorea, on the other hand, it was recently suggested that a cholinergic hypofunction might exist in striatal mechanisms regulating motor activity (Aquilonius and Sjostrbm, 1971) . As Parkinson's disease and Huntington's chorea thus could be in contrasting relationship regarding central cholinergic activity, we found it interesting to study the concentration of Ch in CSF of patients suffering from these two disorders.
METHODS

SELECTION OF PATIENTS AND CONTROLS
The diagnoses of the patients suffering from Parkinson's disease were considered unmistakable in the departments of neurology or neurosurgery. In one group of 16 patients with Parkinson's disease, lumbar punctures (2-3 ml.) were performed with the patients on their usual anticholinergic medication (orphenadrine hydrochloride and/or benzhexol chloride). In 10 patients lumbar punctures were also undertaken, either before treatment had started or after withdrawal of drugs for five days. The patients exhibited more pronounced symptoms without anticholinergic therapy, which could also be documented by objective measurement of rigidity and tremor by a method earlier described (Aquilonius and Tiselius, 1969 Schuberth, 1 Patients were awake at ventriculography, having been given a premedication of triethylperazine (8-6 mg) as suppository and an analgesic containing caffeine (0-2 g), phenacetin (0-6 g) orally 30 min before the examination. in the Parkinsonism group and duration of illness (Fig. 2) or rigidity objectively measured in some of the patients (Fig. 3) . The five patients with tremor dominating showed the same mean value as the rest of the material. A somewhat lower mean value than in the controls was found in the group on L-dopa treatment (Table 1) . In the patients with Huntington's chorea, on the other hand, the mean Ch concentration of lumbar CSF was significantly lower than that in the controls and in the patients with Parkinson's disease. This is true for patients with and without drug therapy (Table 1) . No correlation existed between lumbar CSF Ch concentration and duration of illness (Fig. 4) . The same Ch concentration was found in patients with severe (n = 6) and moderate (n =11) dementia (1 8± 023 and 199+0-10 n-mole/ml respectively). Although a highly significant difference was found between the mean lumbar CFS Ch con- centration of controls and patients with Huntington's chorea, a considerable overlapping between the materials exists (Fig. 5) . This is also seen from the frequency distribution of values Controls 0 (Fig. 6 ).
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DISCUSSION
In the present investigation it has been shown that the lumbar CSF concentration of Ch is rather constant in man. Earlier reported values for human CSF, based on a small number of observations, range from 12-60 n-mole/ml. (Guggenheim and Loffler, 1916) , to values of the same order as ours, 0-5-2-2 n-mole/ml. (Page and Schmidt, 1931) and 0-8-1[6 n-mole/ml. (Bowers, 1967) . In these studies, bioassay determination of the ACh derived from the Ch in the sample, after non-enzymatic acetylation, was used. This involves treatment of the sample with acetic anhydride. Since CSF contains more than 7 n-mole/ml. choline phospholipids (Sastry and Stancer, 1968) , this acetylation procedure may cause an in vitro increase of choline to be acetylated. In fact, Bowers (1967) reported different choline concentrations when acetylation was carried out with acetic anhydride before and after removal of proteins and phospholipids from the CSF. Using the enzymatic acetylation, no such difference in the choline concentration of the CSF was obtained (Schuberth and Sundwall, 1971) . Furthermore, by enzymatic acetylation of CSF Ch with labelled acetyl-CoA, bioassay of ACh is avoided, which is advantageous, since bioassay procedures are not completely specific and the presence of drugs and modifying substances in the samples may interfere with the determination.
Several authors using bioassay have reported ACh-like activity in human lumbar CSF (Schain, 1960) . Whether ACh is a normal constituent of human CSF or not, has, however, been a subject of controversy. Duvoisin and Dettbarn (1967) (Aquilonius and Sjostrom, 1971 (Gardiner and Domer, 1968; Jonsson et al., 1969) . If CSF Ch concentration reflects, to a major part, phospholipid metabolism, the low CSF Ch found in Huntington's chorea might parallel the shrinkage of nervous tissue as well as the reduction of phospholipids in particular reported in the disease (Borri, Opden Velde, Hooghwinkel, and Bruyn, 1967) .
Although it is not known to what extent the CSF Ch is derived from the brain ACh, there are some data in favour of CSF Ch as a marker of central cholinergic activity. Oxotremorine, which decreases acetylcholine turnover in the brain (Schuberth, Sparf, and Sundwall, 1969) and which exerts its main effects on the structures around the lateral ventricles (Bartolini, Bartolini, and Pepeu, 1970; Campbell and Jenden, 1970) , caused a decrease of Ch in the CSF from the lateral ventricle of the dog, while the Ch concentration in the cisternal CSF remained unaltered (Aquilonius, Schuberth, and Sundwall, 1970) . Also, from the results of the amphetamine effect on CSF Ch in man, there is some evidence for a correlation between the Ch concentration in CSF and ACh turnover in the central nervous system. It has been shown that amphetamine causes an increased release of ACh from exposed cortex of experimental animals (Beani, Bianchi, Santinoceto, and Marchetti, 1968) . In accordance with this, it was found that the Ch concentration of lumbar spinal fluid from amphetamine addicts was significantly higher during intoxication than after detoxication (Jonsson et al., 1969) .
If a major part of CSF Ch is derived from ACh hydrolysis in brain regions adjacent to CSF, an increased Ch concentration should be suspected in Parkinson's disease, where a cholinergic overactivity in striatum is likely. The failure to find an increased Ch concentration in lumbar CSF could however be due to the efficient removal of Ch from CSF during the ventriculocisternal passage (Aquilonius and Winbladh, 1971) . For this reason, we studied ventricular and lumbar CSF Ch in five patients with Parkinson's disease undergoing ventriculography. The mean value of ventricular CSF Ch concentration (3-2 + 0-23 n-mol/ml.) was higher than in lumbar CSF (2-6+0-19 n-mole/ml.). In five patients with intention tremor, however, the ventricular CSF Ch concentration was even somewhat higher (3 7 + 045 n-mole/ml.) than in the Parkinsonism group. Conclusions are, however, hard 'to draw from this comparison as nothing is known about central cholinergic mechanism in intention tremor. For obvious reasons, no satisfactory control material of ventricular CSF could be obtained and the wide variation of ventricular CSF Ch concentration in the group consisting mainly of brain tumour cases with increased CSF pressure makes comparison with this material useless.
